Burning Rock Biotech Ltd ADR (BNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -62,412 | N/A | N/A | N/A |
| Depreciation Amortization | 5,105 | N/A | N/A | N/A |
| Accounts receivable | -1,999 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,961 | N/A | N/A | N/A |
| Other Working Capital | 17,180 | N/A | N/A | N/A |
| Other Operating Activity | 26,894 | 0 | 0 | 0 |
| Operating Cash Flow | $-11,271 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -4,662 | N/A | N/A | N/A |
| PPE Investments | -11,482 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -608 | N/A | N/A | N/A |
| Other Investing Activity | -608 | 0 | 0 | 0 |
| Investing Cash Flow | $-16,752 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 766 | N/A | N/A | N/A |
| Debt Issued | 2,790 | N/A | N/A | N/A |
| Debt Repayment | -6,713 | N/A | N/A | N/A |
| Common Stock Issued | 294,121 | N/A | N/A | N/A |
| Other Financing Activity | 40,946 | 0 | 0 | 0 |
| Financing Cash Flow | $331,910 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -23,893 | N/A | N/A | N/A |
| Beginning Cash Position | 15,057 | N/A | N/A | N/A |
| End Cash Position | 295,051 | N/A | N/A | N/A |
| Net Cash Flow | $279,994 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -11,271 | N/A | N/A | N/A |
| Capital Expenditure | -11,581 | N/A | N/A | N/A |
| Free Cash Flow | -22,852 | 0 | 0 | 0 |